Recently, there’s been a noticeable trend of companies planning to exit AIM (Alternative Investment Market) within the last month.
Redx Pharma quits London stock market over its low valuation
Redx Pharma has announced its departure from the London stock market due to a perceived undervaluation, marking it as the second British pharmaceutical firm in the past week to reveal
Share Talk Weekly Small Cap Movers & Shakers, Saturday 21st October 2023
Currently, a trend among small- and microcap companies involves raising modest amounts of capital by selling shares at significantly reduced prices.
Redx Pharma is advancing with ts primary asset, RXC007
Redx Pharma PLC (AIM: REDX) announced that its primary asset, RXC007, is successfully moving through phase IIa testing, with anticipated results from the idiopathic pulmonary fibrosis research due in the
Redx Pharma plc (AIM:REDX) Collaboration with the Garvan Institute
Redx Announces Collaboration with the Garvan Institute of Medical Research
Share Talk Bulletin Board Heroes, Tuesday 4th August 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 2nd July 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Tuesday 30th June 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Bulletin Board Heroes, Extra – Pharma Special, Saturday 23rd May 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Here are our bank holiday
Share Talk Weekly Stock Market News, 13th July 2019
Key Dates For Coming Week
Redx Pharma plc (LON:REDX) Sale of pan-RAF inhibitor programme
Redx to receive $3.5 million upfront, up to $203 million in milestone payments and royalty payments